Full Length Research Paper
References
|
Ajao AO, Johnson JK, Harris AD, Zhan M, McGregor JC, Thom KA, Furuno JP (2013). Risk of acquiring extended-spectrum β-lactamase-producing Klebsiella species and E. coli from prior room occupants in the intensive care unit. Infect. Control. Hosp. Epidemiol. 34(5):453-458. |
|
|
Blomberg B, Jureen R, Manji KP, Tamim BS, Mwakagile DS, Urassa WK, Fataki M, Msangi V, Tellevik MG, Maselle SY, Langeland N (2005). High rate of fatal cases of pediatric septicemia caused by gram-negative bacteria with extended-spectrum beta-lactamases in Dar es Salaam, Tanzania. J. Clin. Microbiol. 43(2):745-749. |
|
|
Bouchillon SK, Johnson BM, Hoban DJ, Johnson JL, Dowzicky MJ, Wu DH, Visalli MA, Bradford PA (2004). Determining incidence of extended spectrum beta-lactamase producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001-2002. Int. J. Antimicrob. Agents 24(2):119-124. |
|
|
Chopra T, Marchaim D, Johnson PC, Chalana IK, Tamam Z, Mohammed M, Alkatib S, Tansek R, Chaudhry K, Zhao JJ, Pogue JM, Kaye KS (2015). Risk factors for bloodstream infection caused by extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae: A focus on antimicrobials including cefepime. Am. J. Infect. Control. 43(7):719-723. |
|
|
Comité de l'antibiogramme de la Société Française de Microbiologie (CASFM) 2016. Recommandations 2016. V.1.0 Février. |
|
|
Dahmen S, Mansour W, Charfi K, Boujaafar N, Arlet G, Bouallegue O (2012). Imipenem resistance in Klebsiella pneumoniae is associated to the combination of plasmid-mediated CMY-4 AmpC β-lactamase and loss of an outer membrane protein. Microb. Drug. Resist. 18(5):479-483. |
|
|
Daikos GL, Tsaousi S, Tzouvelekis LS, Anyfantis I, Psichogiou M, Argyropoulou A, Stefanou I, Sypsa V, Miriagou V, Nepka M, Georgiadou S, Markogiannakis A, Goukos D, Skoutelis A (2014). Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems. Antimicrob. Agents. Chemother. 58(4):2322-2328. |
|
|
Girish N, Saileela K, Mohanty SK (2012). Extended Spectrum β Lactamase Producing Klebsiella pneumoniae and Escherichia coli in Neonatal Intensive Care Unit. J. Bacteriol. Parasitol. 3:141. |
|
|
Lee SY, Park YJ, Yu JK, Jung S, Kim Y, Jeong SH, Arakawa Y (2012). Prevalence of acquired fosfomycin resistance among extended-spectrum b-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3. J. Antimicrob. Chemother. 67(12):2843-2847. |
|
|
Lin CJ, Siu LK, Ma L, Chang YT, Lu PL (2012). Molecular epidemiology of ciprofloxacin-resistant extended-spectrum β-lactamase-producing Klebsiella pneumoniae in Taiwan. Microb. Drug. Resist. 18(1):52-58. |
|
|
Liu HY, Lin HC, Lin YC, Yu SH, Wu WH, Lee YJ (2015). Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella. Int. Urol. Nephrol. 47(7):1059-1066. |
|
|
Lonchel CM, Meex C, Gangoué-Piéboji J, Boreux R, Assoumou MC, Melin P, De mol P (2012). Proportion of extended-spectrum β-lactamase-producing Enterobacteriaceae in community setting in Ngaoundere, Cameroon. BMC Infect. Dis. 12:53. |
|
|
Morosini MI, García-Castillo M, Coque TM, Valverde A, Novais A, Loza E, Baquero F, Cantón R (2006). Antibiotic Co-resistance in Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae and In Vitro Activity of Tigecycline. Antimicrob. Agents. Chimother. 50(8):2695-2699. |
|
|
Nordmann P, Naas T, Poirel L (2011). Global spread of carbapenemase-producing Enterobacteriaceae. Emerg. Infect. Dis. 17(10):1791-1798. |
|
|
Nordmann P, Poirel L (2014). The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide. Clin. Microbiol. Infect. 20(9):821-830. |
|
|
Obeng-Nkrumah N, Twum-Danso K, Krogfelt KA, Newman MJ (2013). High levels of extended-spectrum beta-lactamases in a major teaching hospital in Ghana: The need for regular monitoring and evaluation of antibiotic resistance. Am. J. Trop. Med. Hygien. 89(5):960-964. |
|
|
Oteo J, Bautista V, Lara N, Cuevas O, Arroyo M, Fernández S, Lázaro E, de Abajo FJ, Campos J, Spanish ESBL-EARS-Net Study Group (2010). Parallel increase in community use of fosfomycin and resistance to fosfomycin in extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli. J. Antimicrob. Chemother. 65(11):2459-2463. |
|
|
Paterson DL, Bonomo RA (2005). Extended-Spectrum β-lactamases: A Clinical Update. Clin. Microbiol. Rev. 18(4):657-686. |
|
|
Pitout JD (2010). Infection with extended-spectrum β-lactamases-producing Enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs 70(3):313-333. |
|
|
Pitout JD, Laupland KB (2008). Extended-spectrum β-lactamase-producing Enterobacteriaceae: An emerging public-health concern. Lancet. Infect. Dis. 8(3):159-166. |
|
|
Pitout JDD, Nordmann P, Poirel L (2015). Carbapenemase-Producing Klebsiella pneumoniae, a Key Pathogen Set for Global Nosocomial Dominance. Antimicrob. Agents Chemother. 59(10):5873-5884. |
|
|
Poulou A, Grivakou E, Vrioni G, Koumaki V, Pittaras T, Pournaras S, Tsakris A (2014). Modified CLSI extended-spectrum -lactamase (ESBL) confirmatory test for phenotypic detection of ESBLs among Enterobacteriaceae producing various -lactamases. J. Clin. Microbiol. 52(5):1483-1489. |
|
|
Queenan AM, Bush K (2007). Carbapenemases: The Versatile β-Lactamases. Clin. Microbiol. Rev. 20(3):440-458. |
|
|
Ruppé E, Woerther PL, Barbier F (2015). Mechanisms of antimicrobial resistance in Gram-negative bacilli. Ann. Intensive. Care. 5(1):61. |
|
|
Schaumburg F, Alabi A, Kokou C, Grobusch MP, Köck R, Kaba H, Becker K, Adegnika AA, Kremsner PG, Peters G, Mellmann A (2013). High burden of extended-spectrum β-lactamase-producing Enterobacteriaceae in Gabon. J. Antimicrob. Chemother. 68(9):2140-2143. |
|
|
Severin JA, Mertaniasih NM, Kuntaman K, Lestari ES, Purwanta M, Lemmens-Den Toom N, Duerink DO, Hadi U, van Belkum A, Verbrugh HA, Goessens WH, Study Group 'Antimicrobial Resistance in Indonesia: Prevalence and Prevention' (AMRIN). (2010). Molecular characterization of extended-spectrum beta-lactamases in clinical Escherichia coli and Klebsiella pneumoniae isolates from Surabaya, Indonesia. J. Antimicrob. Chemother. 65(3):465-469. |
|
|
Shukla I, Tiwari R, Agrawal M (2004). Prevalence of extended spectrum-lactamase producing Klebsiella pneumoniae in a tertiary care hospital. Ind. J. Med. Microbiol. 22(2):87-91. |
|
|
Shu JC, Chia JH, Kuo AJ, Su LH, Wu TL (2010). A 7-year surveillance for ESBL-producing Escherichia coli and Klebsiella pneumoniae at a university hospital in Taiwan: the increase of CTX-M-15 in the ICU. Epidemiol. Infect. 138(2):253-263. |
|
|
Simner PJ, Zhanel GG, Pitout J, Tailor F, McCracken M, Mulvey MR, Lagacé-Wiens PR, Adam HJ, Hoban DJ, Canadian Antimicrobial Resistance Alliance (CARA) (2011). Prevalence and characterization of extended-spectrum β-lactamase- and AmpC β-lactamase-producing Escherichia coli: results of the CANWARD 2007-2009 study. Diagn. Microbiol. Infect. Dis. 69(3):326-334. |
|
|
Taneja J, Mishra B, Thakur A, Dogra V, Loomba P (2010). Nosocomial blood-stream infections from extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumonia from GB Pant Hospital, New Delhi. J. Infect. Dev. Ctries. 4(8):517-520. |
|
|
Tumbarello M, Trecarichi EM, De Rosa FG, Giannella M, Giacobbe DR, Bassetti M, Bassetti M, Losito AR, Bartoletti M, Del Bono V, Corcione S, Maiuro G, Tedeschi S, Celani L, Cardellino CS, Spanu T, Marchese A, Ambretti S, Cauda R, Viscoli C, Viale P, ISGRI-SITA (Italian Study Group on Resistant Infections of the Società Italiana Terapia Antinfettiva) (2015). Infections caused by KPC-producing Klebsiella pneumoniae: differ-ences in therapy and mortality in a multicentre study. J. Antimicrob. Chemother. 70(7):2133-2143. |
|
|
Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL (2012). Carbapenemases in Klebsiella pneumoniae and Other Enterobacteriaceae: An Evolving Crisis of Global Dimensions. Clin. Microbiol. Rev. 25(4):682-707. |
|
|
Vasoo S, Barreto JN, Tosh PK (2015). Emerging issues in gram-negative bacterial resistance: an update for the practicing clinician. Mayo. Clin. Proc. 90(3):395-403. |
|
|
Wachino J, Yamane K, Suzuki S, Kimura K, Arakawa Y (2010). Prevalence of fosfomycin resistance among CTX-M-producing Escherichia coli clinical Isolates in Japan and identification of novel plasmid-mediated fosfomycin-modifying enzymes. Antimicrob. Agents. Chemother. 54(7):3061-3064. |
|
|
Zarkotou O, Pournaras S, Tselioti P, Dragoumanos V, Pitiriga V, Ranellou K, Prekates A, Themeli-Digalaki K, Tsakris A (2011). Predictors of mortality in patients with blood stream in fectionscaused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clin. Microbiol. Infect. 17(12):1798-1803. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
